{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:36:59Z","timestamp":1782484619563,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"DOI":"10.7759\/cureus.63368","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T12:48:45Z","timestamp":1719578925000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Characteristics of Patients With Previous Helicobacter pylori Infection-Induced Atrophic Gastritis"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Kishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Takarabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2003.1110604.x","article-title":"Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis","volume":"111","author":"Kokkola A","year":"2003","unstructured":"Kokkola A, Kosunen TU, Puolakkainen P, et al.. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS. 2003, 111:619-24. 10.1034\/j.1600-0463.2003.1110604.x","journal-title":"APMIS"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12669","article-title":"Previous Helicobacter pylori infection-induced atrophic gastritis: a distinct disease entity in an understudied population without a history of eradication","volume":"25","author":"Kishikawa H","year":"2020","unstructured":"Kishikawa H, Ojiro K, Nakamura K, et al.. Previous Helicobacter pylori infection-induced atrophic gastritis: a distinct disease entity in an understudied population without a history of eradication. Helicobacter. 2020, 25:e12669. 10.1111\/hel.12669","journal-title":"Helicobacter"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12210","article-title":"Rate of unintended Helicobacter pylori eradication in the Vietnamese","volume":"20","author":"Hiyama T","year":"2015","unstructured":"Hiyama T, Quach DT, Le QD, et al.. Rate of unintended Helicobacter pylori eradication in the Vietnamese. Helicobacter. 2015, 20:156-7. 10.1111\/hel.12210","journal-title":"Helicobacter"},{"key":"ref4","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa P","year":"1992","unstructured":"Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992, 52:6735-40.","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.87.405","article-title":"Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - \"ABC method\"","volume":"87","author":"Miki K","year":"2011","unstructured":"Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - \"ABC method\". Proc Jpn Acad Ser B Phys Biol Sci. 2011, 87:405-14. 10.2183\/pjab.87.405","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-021-01273-7","article-title":"Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study","volume":"25","author":"Takahashi Y","year":"2022","unstructured":"Takahashi Y, Yamamichi N, Kubota D, et al.. Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study. Gastric Cancer. 2022, 25:481-9. 10.1007\/s10120-021-01273-7","journal-title":"Gastric Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.055400","article-title":"Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study","volume":"54","author":"Watabe H","year":"2005","unstructured":"Watabe H, Mitsushima T, Yamaji Y, et al.. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005, 54:764-8. 10.1136\/gut.2004.055400","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8796165","article-title":"Predicting the development of gastric neoplasia in a healthcare cohort by combining Helicobacter pylori antibodies and serum pepsinogen: a 5-year longitudinal study","volume":"2018","author":"Kwak MS","year":"2018","unstructured":"Kwak MS, Chung GE, Chung SJ, Kang SJ, Yang JI, Kim JS. Predicting the development of gastric neoplasia in a healthcare cohort by combining Helicobacter pylori antibodies and serum pepsinogen: a 5-year longitudinal study. Gastroenterol Res Pract. 2018, 2018:8796165. 10.1155\/2018\/8796165","journal-title":"Gastroenterol Res Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.231512","article-title":"Gastric cancer screening by combined determination of serum Helicobacter pylori antibody and pepsinogen concentrations: ABC method for gastric cancer screening","volume":"131","author":"Chen XZ","year":"2018","unstructured":"Chen XZ, Huang CZ, Hu WX, Liu Y, Yao XQ. Gastric cancer screening by combined determination of serum Helicobacter pylori antibody and pepsinogen concentrations: ABC method for gastric cancer screening. Chin Med J (Engl). 2018, 131:1232-9. 10.4103\/0366-6999.231512","journal-title":"Chin Med J (Engl)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14471","article-title":"Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males","volume":"47","author":"Song M","year":"2018","unstructured":"Song M, Camargo MC, Weinstein SJ, et al.. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther. 2018, 47:494-503. 10.1111\/apt.14471","journal-title":"Aliment Pharmacol Ther"},{"key":"ref11","unstructured":"The Japanese Society for Helicobacter research. reminder regarding the \u201cserum Helicobacter pylori antibody test\u201d result determination (in Japanese). (2015). Accessed: October 3, 2023: https:\/\/www.jshr.jp\/medical\/committee\/file\/past\/20150630_igg.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-016-0682-5","article-title":"Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study","volume":"20","author":"Kiso M","year":"2017","unstructured":"Kiso M, Yoshihara M, Ito M, et al.. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer. 2017, 20:764-71. 10.1007\/s10120-016-0682-5","journal-title":"Gastric Cancer"},{"key":"ref13","article-title":"Predictors of gastric neoplasia in cases negative for Helicobacter pylori antibody and with normal pepsinogen","volume":"35","author":"Kishikawa H","year":"2015","unstructured":"Kishikawa H, Kimura K, Ito A, et al.. Predictors of gastric neoplasia in cases negative for Helicobacter pylori antibody and with normal pepsinogen. Anticancer Res. 2015, 35:6765-71.","journal-title":"Anticancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0993","article-title":"High-negative anti-Helicobacter pylori IgG antibody titers and long-term risk of gastric cancer: results from a large-scale population-based cohort study in Japan","volume":"29","author":"Inoue M","year":"2020","unstructured":"Inoue M, Sawada N, Goto A, Shimazu T, Yamaji T, Iwasaki M, Tsugane S. High-negative anti-Helicobacter pylori IgG antibody titers and long-term risk of gastric cancer: results from a large-scale population-based cohort study in Japan. Cancer Epidemiol Biomarkers Prev. 2020, 29:420-6. 10.1158\/1055-9965.EPI-19-0993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000477239","article-title":"Serological evaluation of gastric cancer risk based on pepsinogen and Helicobacter pylori antibody: relationship to endoscopic findings","volume":"95","author":"Kotachi T","year":"2017","unstructured":"Kotachi T, Ito M, Yoshihara M, et al.. Serological evaluation of gastric cancer risk based on pepsinogen and Helicobacter pylori antibody: relationship to endoscopic findings. Digestion. 2017, 95:314-8. 10.1159\/000477239","journal-title":"Digestion"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02381-z","article-title":"Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings: a large-scale retrospective cohort study","volume":"22","author":"Nagasaki N","year":"2022","unstructured":"Nagasaki N, Ito M, Boda T, Kotachi T, Takigawa H, Oka S, Tanaka S. Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings: a large-scale retrospective cohort study. BMC Gastroenterol. 2022, 22:299. 10.1186\/s12876-022-02381-z","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3521-19","article-title":"Usefulness and limitations of a serum screening system to predict the risk of gastric cancer","volume":"59","author":"Kishino T","year":"2020","unstructured":"Kishino T, Oyama T, Tomori A, Takahashi A, Shinohara T. Usefulness and limitations of a serum screening system to predict the risk of gastric cancer. Intern Med. 2020, 59:1473-80. 10.2169\/internalmedicine.3521-19","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07947-1","article-title":"Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis","volume":"12","author":"Kishikawa H","year":"2022","unstructured":"Kishikawa H, Nakamura K, Ojiro K, et al.. Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis. Sci Rep. 2022, 12:4202. 10.1038\/s41598-022-07947-1","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1098086","article-title":"An endoscopic recognition of the atrophic border and its significance in chronic gastritis","volume":"1","author":"Kimura K","year":"1969","unstructured":"Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969, 1:87-97. 10.1055\/s-0028-1098086","journal-title":"Endoscopy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i43.6078","article-title":"Kyoto classification of gastritis: advances and future perspectives in endoscopic diagnosis of gastritis","volume":"28","author":"Toyoshima O","year":"2022","unstructured":"Toyoshima O, Nishizawa T. Kyoto classification of gastritis: advances and future perspectives in endoscopic diagnosis of gastritis. World J Gastroenterol. 2022, 28:6078-89. 10.3748\/wjg.v28.i43.6078","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1037\/h0031619","article-title":"Measuring nominal scale agreement among several raters","volume":"76","author":"Fleiss JL","year":"1971","unstructured":"Fleiss JL. Measuring nominal scale agreement among several raters. Psychol Bull. 1971, 76:378-82. 10.1037\/h0031619","journal-title":"Psychol Bull"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-017-0901-y","article-title":"Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan","volume":"19","author":"Saito S","year":"2018","unstructured":"Saito S, Azumi M, Muneoka Y, et al.. Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan. Eur J Health Econ. 2018, 19:545-55. 10.1007\/s10198-017-0901-y","journal-title":"Eur J Health Econ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-018-1431-9","article-title":"Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among group A subjects of ABC classification: a multicenter study","volume":"53","author":"Chinda D","year":"2018","unstructured":"Chinda D, Shimoyama T, Mikami T, et al.. Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among group A subjects of ABC classification: a multicenter study. J Gastroenterol. 2018, 53:924-31. 10.1007\/s00535-018-1431-9","journal-title":"J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000469705","article-title":"Cutoff pepsinogen level for predicting unintendedly eradicated cases of Helicobacter pylori infection in subjects with seemingly normal pepsinogen levels","volume":"95","author":"Kishikawa H","year":"2017","unstructured":"Kishikawa H, Kimura K, Ito A, et al.. Cutoff pepsinogen level for predicting unintendedly eradicated cases of Helicobacter pylori infection in subjects with seemingly normal pepsinogen levels. Digestion. 2017, 95:229-36. 10.1159\/000469705","journal-title":"Digestion"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-006-0009-y","article-title":"Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan","volume":"15","author":"Kawai T","year":"2007","unstructured":"Kawai T, Miki K, Ichinose M, et al.. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan. Inflammopharmacology. 2007, 15:31-5. 10.1007\/s10787-006-0009-y","journal-title":"Inflammopharmacology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20200618","article-title":"Long-term response of Helicobacter pylori antibody titer after eradication treatment in middle-aged Japanese: JPHC-NEXT Study","volume":"33","author":"Tanaka S","year":"2023","unstructured":"Tanaka S, Goto A, Yamagishi K, et al.. Long-term response of Helicobacter pylori antibody titer after eradication treatment in middle-aged Japanese: JPHC-NEXT Study. J Epidemiol. 2023, 33:1-7. 10.2188\/jea.JE20200618","journal-title":"J Epidemiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"Ford AC","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020, 69:2113-21. 10.1136\/gutjnl-2020-320839","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3358-5","article-title":"Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital","volume":"18","author":"Luo H","year":"2018","unstructured":"Luo H, Fan Q, Xiao S, Chen K. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital. BMC Health Serv Res. 2018, 18:537. 10.1186\/s12913-018-3358-5","journal-title":"BMC Health Serv Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0187-8","article-title":"Autoimmune gastritis","volume":"6","author":"Lenti MV","year":"2020","unstructured":"Lenti MV, Rugge M, Lahner E, et al.. Autoimmune gastritis. Nat Rev Dis Primers. 2020, 6:56. 10.1038\/s41572-020-0187-8","journal-title":"Nat Rev Dis Primers"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.231","article-title":"Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency","volume":"104","author":"Lahner E","year":"2009","unstructured":"Lahner E, Norman GL, Severi C, et al.. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009, 104:2071-9. 10.1038\/ajg.2009.231","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/257334-clinical-characteristics-of-patients-with-previous-helicobacter-pylori-infection-induced-atrophic-gastritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T12:48:49Z","timestamp":1719578929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/257334-clinical-characteristics-of-patients-with-previous-helicobacter-pylori-infection-induced-atrophic-gastritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.63368","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}